PAMR1 and hepatocellular carcinoma: In addition, PAMR1 and MT1X were closely related to the vital status; both showed low expression in 60.3 % (38/63) of HCC patients with dead status, compared with high expression in 57.4 % (54/94) of patients with alive status (P = 0.022).